Author:
Haarhaus Mathias,Brandenburg Vincent,Kalantar-Zadeh Kamyar,Stenvinkel Peter,Magnusson Per
Publisher
Springer Science and Business Media LLC
Reference193 articles.
1. Levey, A. S. et al. Chronic kidney disease as a global public health problem: approaches and initiatives — a position statement from kidney disease improving global outcomes. Kidney Int. 72, 247–259 (2007).
2. Stenvinkel, P. Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease. J. Intern. Med. 268, 456–467 (2010).
3. Go, A., Chertow, G., Fan, D., McCulloch, C. & Hsu, C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 351, 1296–1305 (2004).
4. Xie, X. et al. Renin-angiotensin system inhibitors and kidney and cardiovascular outcomes in patients with CKD: a Bayesian network meta-analysis of randomized clinical trials. Am. J. Kidney Dis. 67, 728–741 (2016).
5. Palmer, S. C. et al. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst. Rev. 5, CD007784 (2014).
Cited by
230 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献